Myeloid leukemia associated with Down syndrome
Clinical trials for Myeloid leukemia associated with Down syndrome explained in plain language.
Never miss a new study
Get alerted when new Myeloid leukemia associated with Down syndrome trials appear
Sign up with your email to follow new studies for Myeloid leukemia associated with Down syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can tailored chemotherapy tame leukemia in down syndrome?
Disease control OngoingThis phase 3 trial is testing whether adjusting chemotherapy based on a child's early response can improve outcomes for acute myeloid leukemia (AML) or myelodysplastic syndrome in children with Down syndrome. After the first round of treatment, patients are placed into risk group…
Matched conditions: MYELOID LEUKEMIA ASSOCIATED WITH DOWN SYNDROME
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New hope for tough leukemia: drug combo targets hidden cancer cells
Disease control OngoingThis early-phase study tests a new drug called uproleselan combined with two standard chemotherapy drugs for children and teens with acute myeloid leukemia or related blood cancers that have returned or not responded to treatment. The drug works by blocking a protein that helps c…
Matched conditions: MYELOID LEUKEMIA ASSOCIATED WITH DOWN SYNDROME
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC